Skip to content
Oct, 2014 – Envisage LLC – founded in 2014 to identify, create and advanced broad spectrum, immunology drug targets.
To view our 2014 presentation click here:
Envisage LLC – Pharma_non_confidential_October 2014
March, 2015 – Envisage LLC selects targets of interest.
iew our 2015 presentation click here:
Mar 22 2015_Envisage LLC – Organic-Immuno Asset Presentation_Confidential_March 2015.
March 1, 2022
Screen Therapeutics Announces Preliminary Findings on Targeting LAIR-1 and Other ECM Proteins
Screen Therapeutics enters into an immuno-oncology drug development partnership with Immunaccel
March, 2015 –
ENVISAGE and the Wistar Institute forge new venture and value creation partnership
Go to Top